SK Biopharmaceuticals Co., Ltd.

SK Biopharmaceuticals Co., Ltd.

KKRX:326030
85,900.00
KRW
-3,100.00
(-3.48%)
5,004.34EPS
16.91P/E
6.78TMarket Cap
Feb 10Next Earn

SK Biopharmaceuticals Co., Ltd. Documents

Q1 FY2025 · Interim report

May 15, 2025 · 234 pages

Read SK Biopharmaceuticals Co., Ltd.'s results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q1 FY2025 documents